Xiaohua Wei

619 total citations
33 papers, 475 citations indexed

About

Xiaohua Wei is a scholar working on Molecular Biology, Complementary and alternative medicine and Infectious Diseases. According to data from OpenAlex, Xiaohua Wei has authored 33 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Complementary and alternative medicine and 4 papers in Infectious Diseases. Recurrent topics in Xiaohua Wei's work include Renal Transplantation Outcomes and Treatments (4 papers), Traditional Chinese Medicine Analysis (4 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Xiaohua Wei is often cited by papers focused on Renal Transplantation Outcomes and Treatments (4 papers), Traditional Chinese Medicine Analysis (4 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Xiaohua Wei collaborates with scholars based in China, United States and Spain. Xiaohua Wei's co-authors include Harry T. Orr, Hongwei Peng, Yisong Qian, Xuanying Chen, Yanni Lv, Jinhua Wen, Hong Liu, Ying Kong, Jian Zhou and Qun Fu and has published in prestigious journals such as Carbohydrate Polymers, European Journal of Pharmacology and Genomics.

In The Last Decade

Xiaohua Wei

32 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohua Wei China 11 230 101 69 48 45 33 475
Miguel A. Vázquez United States 12 125 0.5× 61 0.6× 37 0.5× 9 0.2× 27 0.6× 15 335
Pooja Popli India 17 214 0.9× 394 3.9× 74 1.1× 67 1.4× 43 1.0× 23 776
Jang-ik Lee United States 2 182 0.8× 133 1.3× 14 0.2× 7 0.1× 33 0.7× 2 413
Yanhua Han China 14 123 0.5× 161 1.6× 179 2.6× 73 1.5× 15 0.3× 26 553
Wenwen Gu China 13 118 0.5× 166 1.6× 29 0.4× 25 0.5× 41 0.9× 39 432
Qiu Yan China 13 73 0.3× 207 2.0× 74 1.1× 13 0.3× 85 1.9× 28 474
Chengfang Yao China 11 112 0.5× 130 1.3× 20 0.3× 8 0.2× 56 1.2× 21 336
Koya Fukunaga Japan 14 64 0.3× 107 1.1× 9 0.1× 36 0.8× 77 1.7× 32 376
Nikola Kotur Serbia 16 62 0.3× 119 1.2× 94 1.4× 73 1.5× 48 1.1× 42 453
Valérie Robin Belgium 8 24 0.1× 215 2.1× 174 2.5× 15 0.3× 19 0.4× 15 474

Countries citing papers authored by Xiaohua Wei

Since Specialization
Citations

This map shows the geographic impact of Xiaohua Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohua Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohua Wei more than expected).

Fields of papers citing papers by Xiaohua Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohua Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohua Wei. The network helps show where Xiaohua Wei may publish in the future.

Co-authorship network of co-authors of Xiaohua Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohua Wei. A scholar is included among the top collaborators of Xiaohua Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohua Wei. Xiaohua Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Xu, Xiaohua Wei, Shaofeng Xiong, et al.. (2025). Punicalin ameliorates vascular endothelial cell pyroptosis and dysfunction induced by hyperlipidemia and hyperglycemia through activation of PPARγ. International Immunopharmacology. 165. 115389–115389. 1 indexed citations
3.
4.
Yan, Jing, et al.. (2023). Personalized Dose of Adjuvant Imatinib in Patients with Gastrointestinal Stromal Tumors: Results from a Population Pharmacokinetic Analysis. Drug Design Development and Therapy. Volume 17. 809–820. 1 indexed citations
5.
Kong, Ying, et al.. (2023). Population pharmacokinetics of mycophenolic acid and dose optimisation in adult Chinese kidney transplant recipients. Xenobiotica. 53(10-11). 603–612. 1 indexed citations
6.
Zhang, Hanxu, Zhuo Zhang, Zhiyan Liu, et al.. (2022). Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic–pharmacodynamic profiles of rivaroxaban. Human Genomics. 16(1). 72–72. 6 indexed citations
7.
Fu, Qun, et al.. (2022). Hematologic toxicities of sunitinib in patients with gastrointestinal stromal tumors: a systematic review and meta-analysis. International Journal of Colorectal Disease. 37(7). 1525–1534. 3 indexed citations
8.
Yan, Jing, Ying Kong, Hong Liu, et al.. (2021). Population pharmacokinetic analysis and dosing guidelines for tacrolimus co‐administration with Wuzhi capsule in Chinese renal transplant recipients. Journal of Clinical Pharmacy and Therapeutics. 46(4). 1117–1128. 23 indexed citations
9.
Peng, Hongwei, et al.. (2020). Pharmacotherapics Advice in Guidelines for COVID-19. Frontiers in Pharmacology. 11. 950–950. 7 indexed citations
10.
Peng, Hongwei, Yunyun Wang, Simei Ren, et al.. (2020). Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs in the Treatment for COVID-19. Frontiers in Pharmacology. 11. 554172–554172. 7 indexed citations
11.
Zhou, Jian, Xiaohua Wei, Fang-You Chen, et al.. (2017). Anti-inflammatory pentacyclic triterpenes from the stems of Euonymus carnosus. Fitoterapia. 118. 21–26. 16 indexed citations
12.
Peng, Hongwei, et al.. (2017). UGT1A1 Gene Polymorphism Predicts Irinotecan-Induced Severe Neutropenia and Diarrhea in Chinese Cancer Patients. Clinical Laboratory. 63(09/2017). 1339–1346. 8 indexed citations
13.
Huang, Haihua, et al.. (2015). Lateral calcaneal artery perforator-based skin flaps for coverage of lower-posterior heel defects. Journal of Plastic Reconstructive & Aesthetic Surgery. 68(4). 571–579. 10 indexed citations
14.
Wen, Jinhua, et al.. (2015). Effect of Ursolic Acid on Breast Cancer Resistance Protein-mediated Transport of Rosuvastatin In Vivo and Vitro. Chinese Medical Sciences Journal. 30(4). 218–225. 10 indexed citations
15.
16.
Lv, Yanni, et al.. (2015). Study on action mechanism of Danhong injection based on computational system biology approach. China Journal of Chinese Materia Medica. 40(3). 538–42. 2 indexed citations
17.
Peng, Hongwei, Xiangfei Yuan, Shiwen Luo, et al.. (2014). Reactive oxygen species contribute to TRAIL receptors upregulation; the mechanism for PH II-7 augmenting TRAIL induced apoptosis in leukemia cells. European Journal of Pharmacology. 746. 344–352. 4 indexed citations
18.
Wei, Xiaohua. (2012). Effect of Danshen on pharmacokinetics of Rosuvastatin in rats. Academic Journal of Second Military Medical University. 2 indexed citations
19.
Wei, Xiaohua, et al.. (1993). Application of cDNA Selection Techniques to Regions of the Human MHC. Genomics. 17(3). 575–581. 20 indexed citations
20.
Wei, Xiaohua & Harry T. Orr. (1990). Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissue. Human Immunology. 29(2). 131–142. 194 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026